Subpopulations of T- and B-lymphocytes in patients with end-stage chronic kidney diseases
https://doi.org/10.28996/2618-9801-2018-4-385-393
Abstract
About the Authors
B. T. DzhumabaevaRussian Federation
L. S. Biryukova
Russian Federation
N. M. Kapranov
Russian Federation
I. V. Galtseva
Russian Federation
Yu. O. Davydova
Russian Federation
N. B. Purlo
Russian Federation
L. R. Karapetyan
Russian Federation
References
1. Girndt M, Sester M, Sester U, Kaul H, Kohler H. Molecular aspects of T- and B-cell function in uremia. Kidney Int Suppl. 2001;78:206-211. Review. Doi:10.1046/j.1523-1755.2001.59780206.
2. Alexiewicz JM, Smogorzewski M, Fadda GZ, Massry SG. Impaired phagocytosis in dialysis patients: studies on mechanisms. Am J Nephrol. 1991;11(2):102-111 Doi:10.1159/000168284
3. Massry S, Smogorzewski M. Dysfunction of polymorphonuclear leukocytes in uremia: role of parathyroid hormone. Kidney Int. 2001;78:195-196. Doi:10.1046/j.1523-1755.2001.59780195.x
4. Степанова Е.Н., Синюхин В.Н., Сивков А.В., Арзуманов С.В., Коробова Т.А. Показатели иммунитета у больных с терминальной стадией почечной недостаточности и уремический токсин пара-крезол (обзор литературы и собственные исследования). Экпериментальная клиническая урология. 2016; 1:112 -119.
5. Agrawal S, Gollapudi P, Elahimehr R, Pahl MV, Vaziri ND. Effects of end-stage renal disease and haemodialysis on dendritic cell subsets and basal and LPS-stimulated cytokine production. Nephrol Dial Transplant. 2010;25(3):737-46. doi: 10.1093/ndt/gfp580.
6. Beaman M, Michael J, MacLennan IC, Adu D. T-cell-independent and T-cell-dependent antibody responses in patients with chronic renal failure. Nephrol Dial Transplant. 1989;4:216-221.
7. Pahl MV, Gollapudi S, Sepassi L, Gollapudi P, Elahimehr R, Vaziri ND. Effect of end-stage renal disease on B-lymphocyte subpopulations, IL-7, BAFF and BAFF receptor expression. Nephrol Dial Transplant. 2010;25(1):205-12. doi: 10.1093/ndt/gfp397.
8. Meier P, Dayer E, Blanc E, Wauters JP. Early T cell activation correlates with expression of apoptosis markers in patients with end-stage renal disease. J Am Soc Nephrol. 2002;13(1):204-212.
9. Matsumoto Y, Shinzato T, Amano I, et al. Relationship between susceptibility to apoptosis and Fas expression in peripheral blood T cells from uremic patients: a possible mechanism for lymphopenia in chronic renal failure. Biochem Biophys Res Commun. 1995;215(1):98-105. Doi:10.1006/bbrc.1995.2438
10. Moser B, Roth G, Brunner M, et al. Aberrant T cell activation and heightened apoptotic turnover in end-stage renal failure patients: a comparative evaluation between non-dialysis, haemodialysis, and peritoneal dialysis. Biochem Biophys Res Commun. 2003;308(3):581-585.
11. Yoon J, Gollapudi S, Pahl M, Vaziri N. Naïve and Central Memory T-cell lymphopenia in end-stage renal disease. Kidney Int. 2006;70(2):371-376 Doi:10.1038/sj.ki.5001550
12. Nosratola D. Vaziri, Madeleine V Pahl, Albert Crum, and Keith Norris. Effect of uremia on structure and function of immune system. J Ren Nutr. 2012; 22(1): 149-156. doi: 10.1053/j.jrn.2011.10.020
13. Hendrikx TK, van Gurp EA, Mol WM, Schoordijk W, Sewgobind VD, Ijzermans JN, Weimar W, Baan CC. End-stage renal failure and regulatory activities of CD4+CD25bright+FoxP3+ T-cells. Nephrol Dial Transplant. 2009;24(6):1969-1978. doi: 10.1093/ndt/gfp005
14. Mansouri L, Nopp A, Jacobson SH, Hylander B, Lundahl J. Hemodialysis Patients Display a Declined Proportion of Th2 and Regulatory T Cells in Parallel with a High Interferon-γ Profile. Nephron. 2017;136(3):254-260. doi: 10.1159/000471814.
Review
For citations:
Dzhumabaeva B.T., Biryukova L.S., Kapranov N.M., Galtseva I.V., Davydova Yu.O., Purlo N.B., Karapetyan L.R. Subpopulations of T- and B-lymphocytes in patients with end-stage chronic kidney diseases. Nephrology and Dialysis. 2018;20(4):385-393. (In Russ.) https://doi.org/10.28996/2618-9801-2018-4-385-393